Rhoen Klinikum AG (WBO:RHK) Moat Score: 5/10 (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:RHK Rhoen Klinikum AG WBO:RHK
77 GF Score
Price €12.90
GF Value €13.56
! 3 Warning Signs
View Full Analysis

What is Rhoen Klinikum AG Moat Score?

Rhoen Klinikum AG WBO:RHK -1.53% 77 Moat Score is 5 as of Jul. 22, 2026. GuruFocus rates WBO:RHK with a GF Score™ of 77/100 and a GF Value™ of €13.56. The stock has 3 warning signs investors should review. Among 672 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks better than 95.98% on this metric.

Rhoen Klinikum AG has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Rhoen Klinikum AG has Narrow Moat: Rhoen Klinikum AG benefits from regulatory barriers in healthcare and a strong distribution network. However, it faces competition and lacks significant pricing power or brand strength, resulting in a solid narrow moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Rhoen Klinikum AG might have Narrow Moat - Solid narrow moat.

Rhoen Klinikum AG  (WBO:RHK) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Rhoen Klinikum AG Moat Score Related Terms

WBO:RHK vs HCA, THC, DVA: Moat Score Comparison

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhoen Klinikum AG Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Moat Score distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's Moat Score falls into.


WBO:RHK
77GF Score
Rhoen Klinikum AG WBO:RHK
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Rhoen Klinikum AG (WBO:RHK) has a Moat Score of 5 as of Jul. 22, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Rhoen Klinikum AG ranks #27 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is Rhoen Klinikum AG's Moat Score too high?
Rhoen Klinikum AG's current Moat Score is 5. Based on the distribution chart, Rhoen Klinikum AG ranks #27 out of 672 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Rhoen Klinikum AG has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's Moat Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #27 out of 672 companies for Moat Score. This places Rhoen Klinikum AG in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Rhoen Klinikum AG's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current Moat Score of 5. The stock's GF Value™ is €13.56, compared to a current price of €12.90 — trading 4.9% below its estimated fair value. The current Moat Score is 5. Rhoen Klinikum AG's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current Moat Score is 5 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?

Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued. The current stock price of €12.90 is trading 4.9% below its estimated GF Value™ of €13.56.

Key valuation signals for WBO:RHK:

  • Moat Score: 5
  • GF Value™: €13.56 vs. price of €12.90 (4.9% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rhoen Klinikum AG Business Description

Other Exchanges 0NQH:UKRHK:Germany
Address Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
77GF Score

Get the complete analysis for WBO:RHK

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.90
Price
€13.56
GF Value